betamethasone valerate has been researched along with Paronychia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belyayeva, E; Gregoriou, S; Katsambas, A; Kontochristopoulos, G; Larios, G; Rigopoulos, D | 1 |
| Bunker, C; Rao, A | 1 |
1 trial(s) available for betamethasone valerate and Paronychia
| Article | Year |
|---|---|
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study.
Topics: Betamethasone Valerate; Candidiasis; Chronic Disease; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Paronychia; Tacrolimus; Treatment Outcome | 2009 |
1 other study(ies) available for betamethasone valerate and Paronychia
| Article | Year |
|---|---|
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study.
Topics: Betamethasone Valerate; Humans; Immunosuppressive Agents; Ointments; Paronychia; Randomized Controlled Trials as Topic; Tacrolimus | 2010 |